Mass General Brigham AI and Digital Innovation Fund Invests in DexCare Series B
Technology offers data-driven management of access to care
DexCare, Inc., a data-driven intelligence company focused on health care access, today announced a $50M Series B funding led by Transformation Capital, with participation from all existing investors, Kaiser Permanente, Providence Ventures, Mass General Brigham, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures. In less than one year, DexCare has closed two oversubscribed funding rounds totaling $71M to-date. Mass General Brigham’s investment is through the AI and Digital Innovation Fund (AIDIF), which focuses on commercial stage digital health and AI-based companies that address unmet needs and are based on technologies emerging from outside Mass General Brigham.
DexCare is a Platform-as-a-Service (PaaS) that intelligently orchestrates digital demand and health system capacity for health systems. DexCare has developed an enterprise-grade, real-time demand aggregation and appointment booking-platform across all lines of care. Health systems across the country have implemented DexCare to expand access to care in more intelligent and data-driven ways that meet the needs of patients while achieving a more balanced and operationally efficient utilization of their resources.
“Consumer expectations for accessing care are changing, and digital-first entrants, like DexCare, are leading the way in responding to this demand for new delivery models,” said Gaye Bok, partner, AIDIF, Mass General Brigham. “The future of integrated care is about providing patients, both new and existing, with easy access to convenient, appropriate, high-quality healthcare and optimizing the experience for consumers and providers. We are pleased to continue our investment in this rapidly growing digital opportunity.”
Related research about artificial intelligence
-
published on
-
published on
-
published on
-
published on
-
published on
-
published on
-
published on
-
published on
-
published on